Core Laboratories sees Q3 EPS 18c-22c vs. 25c last year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 23 2025
0mins
Q3 Revenue Forecast: The company anticipates Q3 revenue to be between $127.5 million and $134.5 million, with a consensus estimate of $130.89 million.
Data Training Cutoff: The information is based on data available up to October 2023.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like CLB with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on CLB
Wall Street analysts forecast CLB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is 11.50 USD with a low forecast of 11.50 USD and a high forecast of 11.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 18.820
Low
11.50
Averages
11.50
High
11.50
Current: 18.820
Low
11.50
Averages
11.50
High
11.50
About CLB
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Christina Lake Cannabis Sells 99 Acres of Non-Core Land for $551,000
- Asset Disposition: Christina Lake Cannabis has completed the sale of 99 acres of non-core land in British Columbia for gross proceeds of $551,000, which will enhance the company's liquidity and improve its balance sheet.
- Strategic Focus: The land sale follows a reassessment of assets post-Midway acquisition, ensuring the company remains focused on its core operating assets to support long-term growth objectives.
- Use of Proceeds: Proceeds from the sale will be allocated to general working capital, further enhancing financial flexibility and supporting future business expansion.
- Market Positioning: As a licensed cannabis producer with over 950,000 square feet of outdoor grow space, Christina Lake Cannabis aims to maintain its competitive edge through this asset optimization in a highly competitive market.
Continue Reading
Core Laboratories Schedules Q4 2025 Earnings Call for February 5, 2026
- Earnings Call Schedule: Core Laboratories will host its Q4 2025 earnings call on February 5, 2026, at 7:30 a.m. CST, where executives will discuss financial and operational results, ensuring timely access to critical information for investors.
- Earnings Release Preview: The company will issue its earnings press release after market close on February 4, 2026, which can be accessed through the company’s website, enhancing transparency and boosting market confidence.
- Webcast Registration: Investors are required to log on to the website at least 15 minutes prior to the call to register for the listen-only webcast, ensuring efficient information dissemination.
- Replay and Transcript Availability: For those unable to attend the live session, a replay and transcript will be available shortly after the call on the company’s website, further improving accessibility of information and communication with investors.
Continue Reading